Tricida
South San Francisco, US · Founded 2013 · Delaware corporation · 6 known investors
Find your way into Tricida
Founders & leadership
Tricida was founded in 2013 by Gerrit Klaerner.
GK
Gerrit KlaernerFounder
MM
Melissa MikschExecutive
Board
SC
Sandra CoufalBoard director
DB
KV
RA
Robert AlpernBoard director
Investors · 6
Avoro Capital AdvisorsNew York
Longitude CapitalMenlo Park · $10M – $30M
Frazier Life SciencesreportedPalo Alto
OrbiMedreported · 2 sourcesNew York · $1M – $75Mvia David Bonita · board
Wellington ManagementreportedBoston · $5M – $50M
Also in the syndicate · 1
Deep Track Capitallead
Reported raises · per SEC filings
Form D private placements$103.1M disclosed across 4 of 5 rounds · 2013–2021
▶$57.6MraisedNov 2017 · 13 investors · PharmaceuticalsRule 506(b)
▶$57.6MraisedNov 2017 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Edward HejlekExecutive Officer
- Klaus VeitingerDirector
- Gerrit KlaernerExecutive Officer, Director
- David HirschDirector
- Jerry BuysseExecutive Officer
- Robert AlpernDirector
- Sandra CoufalDirector
- David BonitaDirector
- Wilhelm StahlExecutive Officer
- Claire LockeyExecutive Officer
- Geoffrey ParkerExecutive Officer
- Offering amount
- $57.6M
- Amount sold
- $57.6M
- First sale
- Nov 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$23.9MraisedJul 2016 · 6 investors · PharmaceuticalsRule 506(b)
▶$23.9MraisedJul 2016 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David BonitaDirector
- David HirschDirector
- Klaus VeitingerDirector
- Robert AlpernDirector
- Sandra CoufalDirector
- Claire LockeyExecutive Officer
- Gerrit KlaernerExecutive Officer, Director
- Jerry BuysseExecutive Officer
- Edward HejlekExecutive Officer
- Offering amount
- $55.5M
- Amount sold
- $23.9M
- First sale
- Jul 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$17.1MraisedFeb 2015 · 4 investors · PharmaceuticalsRule 506(b)
▶$17.1MraisedFeb 2015 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Sandra CoufalDirector
- Melissa MikschExecutive Officer
- David BonitaDirector
- Robert AlpernDirector
- Klaus VeitingerDirector
- Gerrit KlaernerExecutive Officer, Director
- Offering amount
- $30.3M
- Amount sold
- $17.1M
- First sale
- Feb 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$4.5MraisedJan 2014 · 3 investors · PharmaceuticalsRule 506(b)
▶$4.5MraisedJan 2014 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Sandra CoufalDirector
- Robert AlpernDirector
- Gerrit KlaernerExecutive Officer, Director
- Melissa MikschExecutive Officer
- Offering amount
- $13.2M
- Amount sold
- $4.5M
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Tricida?
- Tricida was founded by Gerrit Klaerner in 2013.
- Who are Tricida's investors?
- Tricida's investors include Avoro Capital Advisors, Longitude Capital, Frazier Life Sciences, OrbiMed, Wellington Management.
- How much funding has Tricida raised?
- Tricida has disclosed $103.1M raised across 4 of its 5 known rounds.
- Where is Tricida headquartered?
- Tricida is headquartered in South San Francisco, US.